Letzte Zahlen 22. Juli 2026
Lonza Group AG
I · KI-Analyse
Kurzfassung
Lonza manufactures medicines and biologics under contract for pharmaceutical companies that need specialized production capabilities. They operate three main business lines: Integrated Biologics (growing living cells to make complex drugs), Advanced Synthesis (manufacturing small molecule drugs and antibody-drug conjugates), and Specialized Modalities (cell and gene therapies, mRNA production). Essentially, they are the factory for companies that develop medicines but lack the specialized manufacturing infrastructure to produce them at scale [Yahoo Finance].
Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) that produces complex medicines for pharmaceutical and biotech companies, operating across biologics, small molecules, and specialized therapies like cell and gene treatments [Yahoo Finance]. The company generated CHF 6,5B in revenue but faces moderate financial concerns with negative free cash flow of CHF -204M and a debt load of 2,8x EBITDA [Yahoo Finance]. With 20.000 employees globally, Lonza is positioned in the high-growth biologics manufacturing sector but trades at a premium 37,5x price-to-earnings ratio [Yahoo Finance].
Lonza shows mixed financial health with solid profitability margins but concerning cash flow and elevated debt levels.
Sentinellis-Score
4,2/10
Erhebliche Risiken
Marktkapitalisierung
CHF 34,1B
Umsatz (12 Monate)
CHF 6,5B
Erklärt
Wie wir diese Zahlen lesen
Verständliche Leitfäden · ohne Konto
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LesenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LesenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LesenII · Aktuelle Nachrichten
Was den Kurs bewegt hat
1 Meldung · nach Relevanz sortiert
- Makro2026-05-19
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
Yahoo Finance
Premium · kostenlos mit jedem Konto
Revenue contracted 0,7% year-over-year, indicating potential market headwinds or competitive pressures in Lonza's contract manufacturing segments [Yahoo Finance]
Risiken
5
Chancen
5
Warnsignale
2
Führung
10
11 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.
Vollständige Lonza Group AG-Analyse freischalten
Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.
- 5 Risiken, 5 Chancen und 2 Warnsignale — jeweils mit Quelle
- Über 100 Finanzkennzahlen mit Charts und Vergleichen
- Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
- Führungsteam und Vergütung
III · Ähnliche Unternehmen
Das könnte Sie auch interessieren
Gleicher Sektor · Gesundheitswesen — oder vergleichbare Finanzlage
Auf Ihre Watchlist setzen?